Another shot of Prof. Dan Smith’s presentation at ATW 2026. Did you know that most of the info in this presentation was sourced directly from Nice Insight’s 2026 State of the Industry Report? The open-access report is available for download right now on www.PharmasAlmanac.com.
At Advanced Therapies Week in San Diego, we were honored to secure a speaking slot, where our CSO, Dan, presented on key trends shaping the advanced therapies CDMO landscape.
Nigel, Dan, and Kate are San Diego-bound and excited for another Advanced Therapies week. See you there!
Our team attended the annual JP Morgan Healthcare Conference in San Francisco this week, booking 59 meetings over five days — a successful week without the usual January rain. We look forward to following up over the coming weeks.
We wish Rezon Bio and the entirety of its dynamic team who collaborated on the new brand great success in 2026. Check them out at www.rezonbio.com.
The 2026 sterile market is hot as hell, and the commercial investment into Afton Scientific by Arlington Capital (and the team at That’s Nice) couldn’t be more pleased. Check them out at www.aftonscientific.com.
Protagene, an Ampersand Capital portfolio company, is on the cutting edge of proteomix. We’ve always loved working with this team, and we wish them all the best in the coming year. Check them out at www.protagene.com.
DataHow has just timed the AI/ML market perfectly, as 2026 is, of course, slated to be the year of AI. Check them out at www.datahow.ch.
DIANT Pharma is moving into year five, and the LNP market is picking up. Let’s capitalize on that forward momentum in 2026. Check them out at www.diantpharma.com.
YourBio Health was purchased by Hims & Hers in 2025 from Flagship Pioneering. So, when your GLP-1 injections are virtually painless, these are the guys to thank. Check them out at www.yourbiohealth.com.